|
|
Other links at Articles > Pharmacists |
| 2. |
Enzastaurin Shows Promise as Second- or Third-Line Therapy in NSCLC
|
|
|
Enzastaurin, an oral serine/threonine kinase inhibitor, halted disease progression in some patients with metastatic non-small-cell lung cancer (NSCLC) in a single-arm, phase II study published in the March 1 issue of the Journal of Clinical Oncology. Reuters Health Information
|
| 3. |
Migraine Prophylaxis With Nebivolol Has Few Side Effects
|
|
|
Nebivolol is as effective as metoprolol in the prevention of migraine attacks, but nebivolol is better tolerated and does not require as much dosage adjustment to reach therapeutic levels, researchers in Germany report. Reuters Health Information
|
|
|